Other Species / Isoforms
  EXO1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S68-p
KFVNMLLsHGIKPIL
0 1
EXO1 (human) KFVNMLLsHGIKPIL S68-p
EXO1 (mouse) KFVNMLLSYGVKPIL S68
K185-ub
GCKKVILkMDQFGNG
0 1
EXO1 (human) GCKKVILkMDQFGNG K185-ub
EXO1 (mouse) GCKKVILKMDQFGNG K185
K214-ub
GDVFTEEkFRYMCIL
0 2
EXO1 (human) GDVFTEEkFRYMCIL K214-ub
EXO1 (mouse) GDVFTEEKFRYMCIL K214
Y271-p
NITVPEDyINGFIRA
0 1
EXO1 (human) NITVPEDyINGFIRA Y271-p
EXO1 (mouse) NITVPEDYITGFIRA Y271
Y284-p
RANNTFLyQLVFDPI
0 1
EXO1 (human) RANNTFLyQLVFDPI Y284-p
EXO1 (mouse) RANNTFLYQLVFDPI Y284
K292-ub
QLVFDPIkRKLIPLN
0 1
EXO1 (human) QLVFDPIkRKLIPLN K292-ub
EXO1 (mouse) QLVFDPIQRKLVPLN Q292
S353-p
AMPAHSRsHSWDDKT
Upstream
0 1
Treatment
  • ischemia
EXO1 (human) AMPAHSRsHSWDDKT S353-p
EXO1 (mouse) TMPAHSRSHSWNEKA S352
Y375-p
SSIWHRNysPRPESG
0 1
EXO1 (human) SSIWHRNysPRPESG Y375-p
EXO1 (mouse) NSIWHKNYCPRLEVN Y374
S376-p
SIWHRNysPRPESGT
0 7
EXO1 (human) SIWHRNysPRPESGT S376-p
EXO1 (mouse) SIWHKNYCPRLEVNS C375
K391-ub
VSDAPQLkENPSTVG
0 2
EXO1 (human) VSDAPQLkENPSTVG K391-ub
EXO1 (mouse) VSHAPQLKEKPSTLG K390
S404-p
VGVERVIstkGLNLP
0 1
EXO1 (human) VGVERVIstkGLNLP S404-p
EXO1 (mouse) LGLKQVISTKGLNLP S403
T405-p
GVERVIstkGLNLPR
0 1
EXO1 (human) GVERVIstkGLNLPR T405-p
EXO1 (mouse) GLKQVISTKGLNLPR T404
K406-ub
VERVIstkGLNLPRK
0 1
EXO1 (human) VERVIstkGLNLPRK K406-ub
EXO1 (mouse) LKQVISTKGLNLPRK K405
S415-p
LNLPRKSsIVKRPRs
0 1
EXO1 (human) LNLPRKSsIVKRPRs S415-p
EXO1 (mouse) LNLPRKSCVLKRPRN C414
S422-p
sIVKRPRsAELSEDD
0 5
EXO1 (human) sIVKRPRsAELSEDD S422-p
EXO1 (mouse) CVLKRPRNEALAEDD N421
S454-p
SEGNKSLsFSEVFVP
Upstream
Downstream
1 2
Effects on Modified Protein
  • protein degradation
Treatment
  • hydroxyurea
EXO1 (human) SEGNKSLsFSEVFVP S454-p
EXO1 (mouse) CGDGTSPNSSKMSKS N452
N465
VFVPDLVNGPTNKKS
0 1
EXO1 (human) VFVPDLVNGPTNKKS N465
EXO1 (mouse) MSKSCPDsGtAHKTD S463-p
P467
VPDLVNGPTNKKSVS
0 1
EXO1 (human) VPDLVNGPTNKKSVS P467
EXO1 (mouse) KSCPDsGtAHKTDAH T465-p
T475-p
TNKKSVStPPRtRNk
0 4
EXO1 (human) TNKKSVStPPRtRNk T475-p
EXO1 (mouse) AHKTDAHTPSKMRNK T473
T479-p
SVStPPRtRNkFATF
0 1
EXO1 (human) SVStPPRtRNkFATF T479-p
EXO1 (mouse) DAHTPSKMRNKFATF M477
K482-ac
tPPRtRNkFATFLQR
Upstream
0 6
Treatment
  • MS275
EXO1 (human) tPPRtRNkFATFLQR K482-ac
EXO1 (mouse) TPSKMRNKFATFLQR K480
K482-sm
tPPRtRNkFATFLQR
0 1
EXO1 (human) tPPRtRNkFATFLQR K482-sm
EXO1 (mouse) TPSKMRNKFATFLQR K480
S494-p
LQRKNEEsGAVVVPG
0 1
EXO1 (human) LQRKNEEsGAVVVPG S494-p
EXO1 (mouse) LQRRNEESGAVVVPG S492
T502-p
GAVVVPGtRSRFFCS
0 1
EXO1 (human) GAVVVPGtRSRFFCS T502-p
EXO1 (mouse) GAVVVPGTRSRFFCS T500
S510-p
RSRFFCSsDsTDCVS
0 2
EXO1 (human) RSRFFCSsDsTDCVS S510-p
EXO1 (mouse) RSRFFCSSQDFDNFI S508
S512-p
RFFCSsDsTDCVSNK
0 1
EXO1 (human) RFFCSsDsTDCVSNK S512-p
EXO1 (mouse) RFFCSSQDFDNFIPK D510
K533-ub
DETAVTDkENNLHES
0 1
EXO1 (human) DETAVTDkENNLHES K533-ub
EXO1 (mouse) NETVATGKATTSLLG K532
K548-ub
EYGDQEGkRLVDTDV
0 1
EXO1 (human) EYGDQEGkRLVDTDV K548-ub
EXO1 (mouse) DCPDTEGHKPVDANG H549
T581-p
PDKATVFtDEESYSF
0 1
EXO1 (human) PDKATVFtDEESYSF T581-p
EXO1 (mouse) PGNAAVSPEDEAQSS P572
S598-p
SKFTRTIsPPTLGTL
0 14
EXO1 (human) SKFTRTIsPPTLGTL S598-p
EXO1 (mouse) SKLLGAMsPPSLGTL S589-p
S610-p
GTLRSCFsWSGGLGD
Upstream
0 10
Treatment
  • ischemia
EXO1 (human) GTLRSCFsWSGGLGD S610-p
EXO1 (mouse) GTLRSCFsWSGTLRE S601-p
T621-p
GLGDFSRtPsPSPST
Upstream
Downstream
1 2
Effects on Modified Protein
  • protein degradation
Treatment
  • hydroxyurea
EXO1 (human) GLGDFSRtPsPSPST T621-p
EXO1 (mouse) TLREFSRtPsPSAST T612-p
S623-p
GDFSRtPsPSPSTAL
0 8
EXO1 (human) GDFSRtPsPSPSTAL S623-p
EXO1 (mouse) REFSRtPsPSASTTL S614-p
S639-p
QFRRKSDsPTSLPEN
0 4
EXO1 (human) QFRRKSDsPTSLPEN S639-p
EXO1 (mouse) QFRRKSDPPACLPEA P630
S659-p
SQLKSEEssDDESHP
0 2
EXO1 (human) SQLKSEEssDDESHP S659-p
EXO1 (mouse) CDSKSEMLGETSQPL L652
S660-p
QLKSEEssDDESHPL
0 3
EXO1 (human) QLKSEEssDDESHPL S660-p
EXO1 (mouse) DSKSEMLGETSQPLH G653
S674-p
LREEACSsQSQESGE
0 1
EXO1 (human) LREEACSsQSQESGE S674-p
EXO1 (mouse) LHELGCSSRSQESMD S666
S700-p
SQCSSKDsDsEESDC
0 3
EXO1 (human) SQCSSKDsDsEESDC S700-p
EXO1 (mouse) SQPSSRDSGSEESDC S691
S702-p
CSSKDsDsEESDCNI
0 3
EXO1 (human) CSSKDsDsEESDCNI S702-p
EXO1 (mouse) PSSRDSGSEESDCNN S693
S714-p
CNIKLLDsQSDQTSK
Upstream
Downstream
2 7
Effects on Modified Protein
  • protein degradation
Treatment
  • camptothecin
  • hydroxyurea
  • ionizing_radiation
  • MG132
  • VE822
EXO1 (human) CNIKLLDsQSDQTSK S714-p
EXO1 (mouse) CNNKSLDNQGEQNSK N705
T732-p
SHFSKKDtPLRNKVP
0 2
EXO1 (human) SHFSKKDtPLRNKVP T732-p
EXO1 (mouse) PHFSKKDGLRRNKVP G723
K743-m1
NKVPGLYkSSsADsL
0 1
EXO1 (human) NKVPGLYkSSsADsL K743-m1
EXO1 (mouse) NKVPGLCRSSsMDSF R734
S746-p
PGLYkSSsADsLStT
Upstream
Downstream
2 10
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
Effects on Biological Processes:
  • chromatin organization, altered
  • signaling pathway regulation
Kinase, in vitro:
  • AMPKA1 (human)
  • Chk1 (human)
Putative in vivo kinases:
  • AMPKA1 (mouse)
  • Chk1 (human)
Regulatory protein:
  • CAMKK2 (human)
Treatment
  • A23187
  • aphidicolin
  • AZD7762
  • BAPTA
  • BAPTA-AM
  • compound_C
  • hydroxyurea
  • ischemia
  • siRNA
  • thapsigargin
EXO1 (human) PGLYkSSsADsLStT S746-p
EXO1 (mouse) PGLCRSSsMDSFSTT S737-p
S749-p
YkSSsADsLStTKIK
0 1
EXO1 (human) YkSSsADsLStTKIK S749-p
EXO1 (mouse) CRSSsMDSFSTTKIK S740
T752-p
SsADsLStTKIKPLG
0 1
EXO1 (human) SsADsLStTKIKPLG T752-p
EXO1 (mouse) SsMDSFSTTKIKPLV T743
K784-sm
KHHNAENkPGLQIKL
0 1
EXO1 (human) KHHNAENkPGLQIKL K784-sm
EXO1 (mouse) KHHDVENKPGLQTKI K775
K796-ub
IKLNELWkNFGFKKD
Upstream
0 1
Treatment
  • MG132
EXO1 (human) IKLNELWkNFGFKKD K796-ub
EXO1 (mouse) TKISELWKNFGFKKD K787
S804-p
NFGFKKDsEKLPPCK
0 1
EXO1 (human) NFGFKKDsEKLPPCK S804-p
EXO1 (mouse) NFGFKKDSEKLPSCK S795
S815-p
PPCKKPLsPVRDNIQ
0 9
EXO1 (human) PPCKKPLsPVRDNIQ S815-p
EXO1 (mouse) PSCKKPLSPVKDNIQ S806
T824-p
VRDNIQLtPEAEEDI
0 5
EXO1 (human) VRDNIQLtPEAEEDI T824-p
EXO1 (mouse) VKDNIQLTPETEDEI T815